Potent neutralization by a receptor binding domain monoclonal antibody with broad specificity for SARS-CoV-2 JN.1 and other variants
M. S. Piepenbrink, A. M. Khalil, A. Chang, A. Mostafa, M. Basu, S. Sarkar, S. Panjwani, Y. H. Ha, Y. Ma, C. Ye, Q. Wang, T. J. Green, J. L. Kizziah, N. B. Erdmann, P. A. Goepfert, , J. J. Kobie
This study develops a monoclonal antibody that broadly neutralizes multiple SARS-CoV-2 variants, including JN.1, and shows its protective efficacy in mice.
bioRxiv · Apr 27, 2024 · PreprintImmunology